BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29321510)

  • 61. TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts.
    Noguchi S; Saito A; Mikami Y; Urushiyama H; Horie M; Matsuzaki H; Takeshima H; Makita K; Miyashita N; Mitani A; Jo T; Yamauchi Y; Terasaki Y; Nagase T
    Sci Rep; 2017 Feb; 7():42595. PubMed ID: 28195168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Voisin T; Joannes A; Morzadec C; Lagadic-Gossmann D; Naoures CL; De Latour BR; Rouze S; Jouneau S; Vernhet L
    J Nutr Biochem; 2024 Mar; 125():109558. PubMed ID: 38185349
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.
    Wyman AE; Noor Z; Fishelevich R; Lockatell V; Shah NG; Todd NW; Atamas SP
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L945-L958. PubMed ID: 28385812
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
    Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
    J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endogenous Semaphorin-7A Impedes Human Lung Fibroblast Differentiation.
    Esnault S; Torr EE; Bernau K; Johansson MW; Kelly EA; Sandbo N; Jarjour NN
    PLoS One; 2017; 12(1):e0170207. PubMed ID: 28095470
    [TBL] [Abstract][Full Text] [Related]  

  • 68. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
    Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
    PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
    [TBL] [Abstract][Full Text] [Related]  

  • 70. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
    Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen XM
    Nephrol Dial Transplant; 2014 Feb; 29(2):313-24. PubMed ID: 24166472
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Role of KCNMB1 and BK Channels in Myofibroblast Differentiation and Pulmonary Fibrosis.
    Scruggs AM; Grabauskas G; Huang SK
    Am J Respir Cell Mol Biol; 2020 Feb; 62(2):191-203. PubMed ID: 31486669
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blocking LOXL2 and TGFβ1 signalling induces collagen I turnover in precision-cut lung slices derived from patients with idiopathic pulmonary fibrosis.
    Wei Y; Dong W; Jackson J; Ho TC; Le Saux CJ; Brumwell A; Li X; Klesney-Tait J; Cohen ML; Wolters PJ; Chapman HA
    Thorax; 2021 Jul; 76(7):729-732. PubMed ID: 33472968
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Greater cellular stiffness in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Jaffar J; Yang SH; Kim SY; Kim HW; Faiz A; Chrzanowski W; Burgess JK
    Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L59-L65. PubMed ID: 29516782
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
    Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
    J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fibroblasts from patients with idiopathic pulmonary fibrosis are resistant to cisplatin-induced cell death via enhanced CK2-dependent XRCC1 activity.
    Im J; Nho RS
    Apoptosis; 2019 Jun; 24(5-6):499-510. PubMed ID: 30850922
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition.
    Conte E; Gili E; Fruciano M; Korfei M; Fagone E; Iemmolo M; Lo Furno D; Giuffrida R; Crimi N; Guenther A; Vancheri C
    Lab Invest; 2013 May; 93(5):566-76. PubMed ID: 23439433
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-fibrotic strategies and pulmonary fibrosis.
    Gunatilaka A; Zhang S; Tan WSD; G Stewart A
    Adv Pharmacol; 2023; 98():179-224. PubMed ID: 37524487
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury.
    Bulvik R; Biton M; Berkman N; Breuer R; Wallach-Dayan SB
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210149
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
    Mackinnon AC; Gibbons MA; Farnworth SL; Leffler H; Nilsson UJ; Delaine T; Simpson AJ; Forbes SJ; Hirani N; Gauldie J; Sethi T
    Am J Respir Crit Care Med; 2012 Mar; 185(5):537-46. PubMed ID: 22095546
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
    Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
    Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.